ランキング価格はじめての方へ
  1. 米国企業
  2. MoonLake Immunotherapeutics

MoonLake ImmunotherapeuticsMLTX

時価総額
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Cash and cash equivalents1666,79040451
Short-term marketable debt securities--3360
Other receivables--217,1291
Prepaid Expense, Current283,057126,91642
Total current assets2793,70677514
Operating lease right-of-use assets--282,5804
Property and equipment, net--49,389320,865
Total non-current assets115115331,96912
Prepaid Expense, Noncurrent---8
Total non-current assets115115331,96912
Total assets11711677527
Trade and other payables--254,9722
Operating Lease, Liability, Current--01
Accrued Liabilities and Other Liabilities--77
Accrued Liabilities and Other Liabilities--77
Total current liabilities125,1834810
Total current liabilities125,1834810
Operating Lease, Liability, Noncurrent--128,9512
Pension liability--282,206583,426
Total non-current liabilities44411,1573
Total liabilities48813
Common Class A118-3,8986,047
Common Class C--1,373251
Common Class A118-3,8986,047
Common Class C--1,373251
Common Shares-43--
Common Class A118-3,8986,047
Common Class C--1,373251
Common Class A118-3,8986,047
Common Class C--1,373251
Common Shares-43--
Additional paid-in capital5-129610
Accumulated deficit-90,838-7,059,268-80,650,212-116,657,472
Additional paid-in capital5-129610
Accumulated other comprehensive income--350,9462
Accumulated deficit-90,838-7,059,268-80,650,212-116,657,472
Common Class A118---
Common Class A118---
Total shareholders’ equity5-7,058,93769513
Accumulated other comprehensive income--350,9462
Noncontrolling interests--2018
Common Class A118---
Common Class A118---
Total shareholders’ equity5-7,058,93769513
Common Class A--3,8986,047
Common Class C--1,373251
Common Class A--3,8986,047
Common Class C--1,373251
Total equity--69513
Noncontrolling interests--2018
Common Class A--3,8986,047
Common Class C--1,373251
Common Class A--3,8986,047
Common Class C--1,373251
Total equity--69513
Total liabilities and equity11711677527